Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.200
+0.090 (4.27%)
At close: Mar 13, 2025, 4:00 PM
2.260
+0.060 (2.73%)
Pre-market: Mar 14, 2025, 8:01 AM EST

Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $58.36 million. The enterprise value is $47.08 million.

Market Cap 58.36M
Enterprise Value 47.08M

Important Dates

The next estimated earnings date is Tuesday, March 25, 2025, before market open.

Earnings Date Mar 25, 2025
Ex-Dividend Date n/a

Share Statistics

GANX has 26.53 million shares outstanding. The number of shares has increased by 61.20% in one year.

Current Share Class 26.53M
Shares Outstanding 26.53M
Shares Change (YoY) +61.20%
Shares Change (QoQ) +38.07%
Owned by Insiders (%) 4.90%
Owned by Institutions (%) 7.49%
Float 25.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 6.41
P/TBV Ratio 6.67
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.09.

Current Ratio 2.99
Quick Ratio 2.70
Debt / Equity 0.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -263.14% and return on invested capital (ROIC) is -148.44%.

Return on Equity (ROE) -263.14%
Return on Assets (ROA) -94.13%
Return on Invested Capital (ROIC) -148.44%
Return on Capital Employed (ROCE) -219.35%
Revenue Per Employee n/a
Profits Per Employee -$667,717
Employee Count 32
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, GANX has paid $46,579 in taxes.

Income Tax 46,579
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -51.75% in the last 52 weeks. The beta is 0.14, so GANX's price volatility has been lower than the market average.

Beta (5Y) 0.14
52-Week Price Change -51.75%
50-Day Moving Average 2.22
200-Day Moving Average 1.81
Relative Strength Index (RSI) 53.71
Average Volume (20 Days) 245,683

Short Selling Information

The latest short interest is 462,159, so 1.74% of the outstanding shares have been sold short.

Short Interest 462,159
Short Previous Month 365,119
Short % of Shares Out 1.74%
Short % of Float 1.83%
Short Ratio (days to cover) 1.44

Income Statement

Revenue n/a
Gross Profit -11.46M
Operating Income -21.43M
Pretax Income -21.54M
Net Income -21.37M
EBITDA -21.39M
EBIT -21.43M
Earnings Per Share (EPS) -$1.08
Full Income Statement

Balance Sheet

The company has $12.05 million in cash and $769,413 in debt, giving a net cash position of $11.28 million or $0.43 per share.

Cash & Cash Equivalents 12.05M
Total Debt 769,413
Net Cash 11.28M
Net Cash Per Share $0.43
Equity (Book Value) 8.91M
Book Value Per Share 0.34
Working Capital 9.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.08 million and capital expenditures -$21,567, giving a free cash flow of -$21.10 million.

Operating Cash Flow -21.08M
Capital Expenditures -21,567
Free Cash Flow -21.10M
FCF Per Share -$0.80
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -61.20%
Shareholder Yield -61.20%
Earnings Yield -36.62%
FCF Yield -36.16%

Analyst Forecast

The average price target for GANX is $8.33, which is 278.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.33
Price Target Difference 278.64%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 172.08%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GANX has an Altman Z-Score of -6.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.69
Piotroski F-Score 3